Evidence method
Level · gp.fundamentals.debt_to_revenue
29.51% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
PBYI · Dec 31, 2024
PUMA BIOTECHNOLOGY, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-25-005496General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-2.19% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
3.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
72.06% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
13.44% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.58% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/5 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20255/8 normalizedLevel 3Sep 30, 20256/8 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 98.50%
- Current
- 29.51%
- Delta
- -69.00%
- Previous
- 0.02%
- Current
- 0.02%
- Delta
- -0.00%
- Previous
- 13.70%
- Current
- 16.89%
- Delta
- 3.18%
- Previous
- 43.53%
- Current
- -2.19%
- Delta
- -45.72%
- Previous
- 3.32%
- Current
- 3.79%
- Delta
- 0.47%
- Previous
- 63.87%
- Current
- 72.06%
- Delta
- 8.18%
- Previous
- 27.41%
- Current
- 13.44%
- Delta
- -13.98%
- Previous
- 2.55%
- Current
- 3.58%
- Delta
- 1.03%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · PBYI Fundamental State →Has State · PUMA BIOTECHNOLOGY, INC. →Transitioned To · PBYI INVENTORY_PRESSURE_INCREASED →Transitioned To · PBYI MARGIN_INCREASED →Transitioned To · PBYI PROFITABILITY_DECREASED →Transitioned To · PBYI SBC_INTENSITY_INCREASED →Transitioned To · PBYI Fundamental State →Transitioned To · PBYI BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PBYI CAPEX_INTENSITY_DECREASED →Transitioned To · PBYI CASH_GENERATION_INCREASED →Transitioned To · PBYI GROWTH_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.